MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jtm/taac109

Медицинская библиотека · Journal of travel medicine · 2022

Duration of immune protection of SARS-CoV-2 natural infection against reinfection.

Chemaitelly Hiam, Nagelkerke Nico, Ayoub Houssein H, Coyle Peter, Tang Patrick, Yassine Hadi M, Al-Khatib Hebah A, Smatti Maria K, Hasan Mohammad R, Al-Kanaani Zaina, Al-Kuwari Einas, Jeremijenko Andrew, Kaleeckal Anvar Hassan, Latif Ali Nizar, Shaik Riyazuddin Mohammad, Abdul-Rahim Hanan F, Nasrallah Gheyath K, Al-Kuwari Mohamed Ghaith, Butt Adeel A, Al-Romaihi Hamad Eid, Al-Thani Mohamed H, Al-Khal Abdullatif, Bertollini Roberto, Abu-Raddad Laith J

СтатьяПеревод требует повторной обработки

Аннотация

BACKGROUND

The future of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic hinges on virus evolution and duration of immune protection of natural infection against reinfection. We investigated the duration of protection afforded by natural infection, the effect of viral immune evasion on duration of protection and protection against severe reinfection, in Qatar, between 28 February 2020 and 5 June 2022.

METHODS

Three national, matched, retrospective cohort studies were conducted to compare the incidence of SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19) severity among unvaccinated persons with a documented SARS-CoV-2 primary infection, to incidence among those infection-naïve and unvaccinated. Associations were estimated using Cox proportional hazard regression models.

RESULTS

Effectiveness of pre-Omicron primary infection against pre-Omicron reinfection was 85.5% [95% confidence interval (CI): 84.8-86.2%]. Effectiveness peaked at 90.5% (95% CI: 88.4-92.3%) in the 7th month after the primary infection, but waned to ~ 70% by the 16th month. Extrapolating this waning trend using a Gompertz curve suggested an effectiveness of 50% in the 22nd month and < 10% by the 32nd month. Effectiveness of pre-Omicron primary infection against Omicron reinfection was 38.1% (95% CI: 36.3-39.8%) and declined with time since primary infection. A Gompertz curve suggested an effectiveness of < 10% by the 15th month. Effectiveness of primary infection against severe, critical or fatal COVID-19 reinfection was 97.3% (95% CI: 94.9-98.6%), irrespective of the variant of primary infection or reinfection, and with no evidence for waning. Similar results were found in sub-group analyses for those ≥50 years of age.

CONCLUSIONS

Protection of natural infection against reinfection wanes and may diminish within a few years. Viral immune evasion accelerates this waning. Protection against severe reinfection remains very strong, with no evidence for waning, irrespective of variant, for over 14 months after primary infection.

Для цитирования: Chemaitelly Hiam, Nagelkerke Nico, Ayoub Houssein H, Coyle Peter, Tang Patrick, Yassine Hadi M, Al-Khatib Hebah A, Smatti Maria K, Hasan Mohammad R, Al-Kanaani Zaina, Al-Kuwari Einas, Jeremijenko Andrew, Kaleeckal Anvar Hassan, Latif Ali Nizar, Shaik Riyazuddin Mohammad, Abdul-Rahim Hanan F, Nasrallah Gheyath K, Al-Kuwari Mohamed Ghaith, Butt Adeel A, Al-Romaihi Hamad Eid, Al-Thani Mohamed H, Al-Khal Abdullatif, Bertollini Roberto, Abu-Raddad Laith J. Duration of immune protection of SARS-CoV-2 natural infection against reinfection.. Journal of travel medicine. 2022. DOI: 10.1093/jtm/taac109.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.